Related Experiment Videos
Immature host for xenotransplantation
R E Michler1, O P Minanov, J H Artrip
1Division of Cardiothoracic Surgery, College of Physicians and Surgeons, Columbia University, New York, New York 10032, USA.
World Journal of Surgery
|November 15, 1997
Summary
Pig organs show promise for infant heart transplants, avoiding hyperacute rejection. Further research aims to extend graft survival beyond seven days for bridging until human donors are available.
Area of Science:
- Transplantation immunology
- Xenotransplantation
- Pediatric cardiology
Background:
- Severe shortage of human donor hearts for newborns.
- Pig organs are a potential alternative source.
- Xenotransplantation faces immunological barriers like hyperacute rejection.
Purpose of the Study:
- Investigate pig cardiac xenograft survival in newborn baboons.
- Characterize the rejection process in this model.
- Evaluate immunosuppressive strategies to prolong graft life.
Main Methods:
- Transplantation of pig cardiac xenografts into newborn baboons.
- Monitoring for hyperacute rejection and subsequent immune responses.
- Administration of cyclosporine-based triple immunosuppression.
Main Results:
- Newborn baboons did not experience hyperacute rejection of pig xenografts.
- Rejection occurred around days 3-4, mediated by natural killer cells and macrophages.
- Immunosuppression prolonged graft survival to 6-7 days but did not prevent humoral rejection.
Conclusions:
- Newborn recipients may tolerate pig xenografts better than adults.
- Novel strategies are needed to overcome humoral rejection and complement-mediated damage.
- Transgenic pig organs and advanced immunosuppression could enable xenografts as a bridge to human transplantation.